King & Spalding LLP

Atlanta, GA Professional servicesNAICS 541110

Self-funded health planPlan year 2025Renews January
2,272Participants+1% vs. prior year
$5.4MEst. pharmacy spend / yrParticipants × national avg.
Jan 2027Next renewalPlan year begins January 1
#4 of 28Professional services in GABy participants

Overview

King & Spalding LLP sponsors a self-funded health plan that covered 2,272 participants in plan year 2025, about the same as the prior year. The plan year starts in January. Alongside medical, its benefits filing reports life insurance, dental, vision, short-term disability, and more.

Plan type
ERISA welfare benefit plan, self-funded (benefits paid from employer assets or a trust)
Participants
2,272 · prior year 2,244
Plan year
Begins January 1 · next renewal January 2027
Health plans filed
King & Spalding LLP Group Life & Health Plan, plan 502 (2,272 participants)
Stop-loss carrier
Cigna Health Life Insurance Company and Affiliates (cigna)
Broker compensation
$599K across insured contracts
MedicalLife insuranceDentalVisionShort-term disabilityLong-term disabilitySeveranceDeath benefitsOther welfare benefits

Insurance carriers

Insured coverage reported on Schedule A. Self-funded medical claims aren't reported there.

CarrierCoverageCoveredPremiumBroker comp
Unum Life Insurance Company of AmericaLong-term disability, Life2,080$5.2M$551K
Cigna Health and Life Insurance CompanyMedical, Dental, Life, Long-term disability253$2.7M—
Cigna Health Life Insurance Company and Affiliates (cigna)Stop-loss3,571$2.0M—
Delaware American Life Insurance of AmericaLife, Long-term disability253$312K—
John Hancock Life Insurance CompanyGroup Long-Term Care64$163K$21K
United Healthcare Insurance CompanyVision2,255$148K—
First Unum Life Insurance CompanyShort-term disability351$143K$7K
Genworth Life Insurance CompanyLong Term Care76$140K$12K
Colonial Life & Accident Insurance CompanyCancer74$47K$4K
Zurich American Insurance CompanyAccidental Death and Dismemberment2,385$9K$1K

Pharmacy benefit estimate

StreamRX estimate for a plan this size. Not based on this plan's claims.

$5.4M/ year

Estimated prescription spend: 2,272 participants × $2,371 national average per member. Usually higher once dependents are counted.

$140K–$345K/ year

Typical savings opportunity found in independent reviews of plans this size.

Brands with a generic available$41K–$102K
Lower-cost therapeutic alternatives$60K–$125K
Generic pricing vs. actual cost$26K–$78K
PBM contract terms$13K–$40K
The DOL's PBM fee disclosure rule first applies to this plan for the plan year beginning January 2028: semiannual PBM compensation reports and an annual audit right.

Form 5500 filing details

Filing
Form 5500 with Schedule A, plan year 2025
Plan sponsor
King & Spalding LLP
Sponsor EIN
58-0520153
Plan number
502
Filed with
U.S. Department of Labor (EBSA) via EFAST2

Verify this filing: search EIN 58-0520153 in the Department of Labor's EFAST2 Form 5500 search.

Retirement plan

Plan
King & Spalding LLP Profit Sharing - 401(k) Plan
Type
401(k) plan
Participants
3,265

About this data

Source: King & Spalding LLP's Form 5500 filing for plan year 2025 and its Schedule A insurance reports, published by the U.S. Department of Labor. "Self-funded" means the filing reports benefits paid from employer assets or a trust, with no medical insurance contract or with a stop-loss contract. Pharmacy figures are StreamRX estimates based on national averages. StreamRX is not affiliated with King & Spalding LLP.

Request a correction · Methodology